rawfin.tv
Trump Administration Plans to Ease Access to Psychedelics for Research
RegulationmacroAI Generated

Trump Administration Plans to Ease Access to Psychedelics for Research

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

The Trump administration plans to direct federal agencies to increase research and support clinical trials for psychedelics like psilocybin and ibogaine. This initiative aims to ease access to these substances for therapeutic purposes.

TrumpPsychedelicsRegulationHealthcareBiotechPolicy

Related Articles

Daily Market Overview — October 22, 2026

Daily Market Overview — October 22, 2026

macro
BOE Rate Outlook Clouded by Energy Uncertainty as Barclays Announces Buyback

BOE Rate Outlook Clouded by Energy Uncertainty as Barclays Announces Buyback

macro
Bank of Korea Holds Interest Rate Steady at 3% Following Rate Hikes

Bank of Korea Holds Interest Rate Steady at 3% Following Rate Hikes

macro
Bank of Korea Holds Benchmark Rate Steady

Bank of Korea Holds Benchmark Rate Steady

macro